A retrospective study on the effects of pulmonary rehabilitation in patients with pulmonary hypertension

Chronic Respiratory Disease

Volumn 11, Issue 3, 2014, Pages 153-162

  Raskin, Jonathan ^a   Qua, Debbie ^a   Marks, Ted ^a   Sulica, Roxana ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

exercise; PAH pharmacotherapy and 6 minute walk; pulmonary hypertension; Pulmonary rehabilitation; rehabilitation; rehabilitation in PH; six minute walk test

Indexed keywords

EID: 84905726532     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314538980     Document Type: Article

References (32)

1. Badesch DB, Champion HC, Gomez Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009 ; 54: S55 - S66
2. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 ; 114: 1482-1489
3. Man FS, Handoko ML, Groepenhoff AJ. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Resp J. 2009 ; 34: 669-675
4. Grünig E, Ehlken N, Ghofrani H, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011 ; 81: 394-401
5. Chan L, Chin LM, Kennedy M, et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013 ; 143 ((2)). 333-343
6. Mainguy V, Maltais F, Saey D, et al. Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2010 ; 30 ((5)). 319-323
7. Grünig E, Lichtblau M, Ehlken N, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012 ; 40 ((1)). 84-92
8. Fox BD, Kassirer M, Weiss I, et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail. 2011 ; 17 ((3)). 196-200
9. Mainguy V, Maltais F, Saey D, et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010 ; 65: 113-117
10. Nagel C, Prange F, Guth S, et al. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS ONE. 2012 ; 7 ((7)). e41603
11. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013 ; 62 ((25 Suppl)). D34 - D41
12. Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007 ; 30: 1103-1110
13. Provencher S, Herve P, Sitbon O, et al. Changes in exercise hemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J. 2008 ; 32: 393-398
14. Nici L, Donner C, Wouters E, et al. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006 ; 173: 1390-1413
15. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006 ; 18: CD003793
16. Ferreira A, Garvey C, Conners GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest. 2009 ; 135: 442-447
17. Galiè N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009 ; 30: 394-403
18. Desai SA, Channick RN. Exercise in patients with pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2008 ; 28: 12-16
19. Meyer FJ, Lossnitzer D, Kristen AV, et al. Borst respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005 ; 25: 125-130
20. Puhan MA, Chandra D, Mosenifar Z, et al. National Emphysema Treatment Trial (NETT) Research Group. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011 ; 37 (4). 784-790
21. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014 ; 108 ((1)). 203-210
22. Gremeaux V, Troisgros O, Benaim S, et al. Determining the minimal clinically important difference for the six minute walk test and the 200-meter fast-walk test during cardiac rehabilitation program in coronary artery disease patients after acute coronary syndrome. Arch Phys Med Rehabil. 2011 ; 92 ((4)). 611-619
23. Mathai SC, Puhan MA, Lam D, et al. The minimal important difference in the 6-minute walk test for patients with pulmonary. Am J Respir Crit Care Med. 2012 ; 186 ((5)). 428-433
24. Gilbert Brown MC, Cappelleri JC, et al. Estimating a minimally important difference in PH following treatment with Sildenafil. Chest. 2009 ; 1135 ((1)). 137-142
25. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997 ; 155: 1278-1282
26. Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2012 ; 39: 589-596
27. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD Candidates for lung volume reduction surgery or lung transplantation. Chest. 2005 ; 127: 1531-1536
28. Oswald-Mammosser Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving LTOT. Chest. 1995 ; 107: 1193-1198
29. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009 ; 30 ((20)). 2493-2537
30. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000 ; 161: 487-492
31. Macchia A, Marchioli R, Marfisi R, et al. A meta-analysis of trials of pulmonary7 hypertension: a clinical condition looking for drugs and research methodology. Am Heart J. 2007 ; 153: 1037-1047
32. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010 ; 122: 164-172